161 related articles for article (PubMed ID: 35999193)
41. Burosumab for the treatment of cutaneous-skeletal hypophosphatemia syndrome.
Abebe L; Phung K; Robinson ME; Waldner R; Carsen S; Smit K; Tice A; Lazier J; Armour C; Page M; Dover S; Rauch F; Koujok K; Ward LM
Bone Rep; 2024 Mar; 20():101725. PubMed ID: 38229908
[TBL] [Abstract][Full Text] [Related]
42. Epidermal nevus syndrome with hypophosphatemic rickets in a young girl.
Sukkhojaiwaratkul D; Mahachoklertwattana P; Poomthavorn P
J Paediatr Child Health; 2014 Jul; 50(7):566-9. PubMed ID: 24372733
[TBL] [Abstract][Full Text] [Related]
43. Polyostotic osteolysis and hypophosphatemic rickets with elevated serum fibroblast growth factor 23: A case report.
Sato T; Muroya K; Asakura Y; Yachie A; Nishimura G; Aida N; Machida J; Tanaka Y; Hasegawa T; Adachi M
Am J Med Genet A; 2015 Oct; 167A(10):2430-4. PubMed ID: 26059403
[TBL] [Abstract][Full Text] [Related]
44. Efficient Suppression of NRAS-Driven Melanoma by Co-Inhibition of ERK1/2 and ERK5 MAPK Pathways.
Adam C; Fusi L; Weiss N; Goller SG; Meder K; Frings VG; Kneitz H; Goebeler M; Houben R; Schrama D; Schmidt M
J Invest Dermatol; 2020 Dec; 140(12):2455-2465.e10. PubMed ID: 32376279
[TBL] [Abstract][Full Text] [Related]
45. Hypophosphatemic rickets associated with giant hairy nevus.
Aggarwal S; Sharma NN; Singhania DK; Dhoot DK
Indian J Endocrinol Metab; 2013 Oct; 17(Suppl 1):S188-90. PubMed ID: 24251154
[TBL] [Abstract][Full Text] [Related]
46. Malignant melanoma arising from an NRAS-mutated medium-sized congenital melanocytic nevus.
Kiyohara T; Takata M; Itoh H; Kawami K; Ido H; Ishida H; Kumakiri M
J Dermatol; 2012 Dec; 39(12):1034-5. PubMed ID: 22452623
[No Abstract] [Full Text] [Related]
47. Congenital Melanocytic Nevus Syndrome: A Case Series.
Recio A; Sánchez-Moya AI; Félix V; Campos Y
Actas Dermosifiliogr; 2017 Nov; 108(9):e57-e62. PubMed ID: 28110826
[TBL] [Abstract][Full Text] [Related]
48. BRAF, NRAS, and GNAQ Mutations in Conjunctival Melanocytic Nevi.
Francis JH; Grossniklaus HE; Habib LA; Marr B; Abramson DH; Busam KJ
Invest Ophthalmol Vis Sci; 2018 Jan; 59(1):117-121. PubMed ID: 29332123
[TBL] [Abstract][Full Text] [Related]
49. Vitamin D-resistant rickets associated with epidermal nevus syndrome: demonstration of a phosphaturic substance in the dermal lesions.
Aschinberg LC; Solomon LM; Zeis PM; Justice P; Rosenthal IM
J Pediatr; 1977 Jul; 91(1):56-60. PubMed ID: 195029
[TBL] [Abstract][Full Text] [Related]
50. Aggressive melanoma in an infant with congenital melanocytic nevus syndrome and multiple, NRAS and BRAF mutation-negative nodules.
de la Rosa Carrillo D; Vindenes H; Kinsler VA; Rønnestad A; Ringstad G; Müller LO; Tafjord S; Tønseth KA; Kvamme B; Clausen OPF
Pediatr Dermatol; 2018 Sep; 35(5):e281-e285. PubMed ID: 29999207
[TBL] [Abstract][Full Text] [Related]
51. Topical trametinib for epidermal and sebaceous nevi in a child with Schimmelpenning-Feuerstein-Mims syndrome.
Haller CN; Leszczynska MA; Brichta L; Maier E; Riddington IM; Choate KA; Levy ML
Pediatr Dermatol; 2024; 41(3):523-525. PubMed ID: 38273779
[TBL] [Abstract][Full Text] [Related]
52. Making a mountain out of a molehill: NRAS, mosaicism, and large congenital nevi.
Gerami P; Paller AS
J Invest Dermatol; 2013 Sep; 133(9):2127-30. PubMed ID: 23949765
[TBL] [Abstract][Full Text] [Related]
53. Loss of NF1 in cutaneous melanoma is associated with RAS activation and MEK dependence.
Nissan MH; Pratilas CA; Jones AM; Ramirez R; Won H; Liu C; Tiwari S; Kong L; Hanrahan AJ; Yao Z; Merghoub T; Ribas A; Chapman PB; Yaeger R; Taylor BS; Schultz N; Berger MF; Rosen N; Solit DB
Cancer Res; 2014 Apr; 74(8):2340-50. PubMed ID: 24576830
[TBL] [Abstract][Full Text] [Related]
54. Genetic analyses of mosaic neurofibromatosis type 1 with giant café-au-lait macule, plexiform neurofibroma and multiple melanocytic nevi.
Hida T; Idogawa M; Okura M; Sugita S; Sugawara T; Sasaki Y; Tokino T; Yamashita T; Uhara H
J Dermatol; 2020 Jun; 47(6):658-662. PubMed ID: 32246533
[TBL] [Abstract][Full Text] [Related]
55. Genetic Abnormalities in Large to Giant Congenital Nevi: Beyond NRAS Mutations.
Martins da Silva V; Martinez-Barrios E; Tell-Martí G; Dabad M; Carrera C; Aguilera P; Brualla D; Esteve-Codina A; Vicente A; Puig S; Puig-Butillé JA; Malvehy J
J Invest Dermatol; 2019 Apr; 139(4):900-908. PubMed ID: 30359577
[TBL] [Abstract][Full Text] [Related]
56. Naevus spilus-type congenital melanocytic naevus associated with a novel NRAS codon 61 mutation.
Krengel S; Widmer DS; Kerl K; Levesque MP; Schiestl C; Weibel L
Br J Dermatol; 2016 Mar; 174(3):642-4. PubMed ID: 26302237
[No Abstract] [Full Text] [Related]
57. Massively parallel sequencing analysis of benign melanocytic naevi.
Lozada JR; Geyer FC; Selenica P; Brown D; Alemar B; Merghoub T; Berger MF; Busam KJ; Halpern AC; Weigelt B; Reis-Filho JS; Hollmann TJ
Histopathology; 2019 Jul; 75(1):29-38. PubMed ID: 30791119
[TBL] [Abstract][Full Text] [Related]
58. Spatiotemporal expression of NRAS and occurrence of giant congenital melanocytic nevi.
Aimaier R; Chung M; Zhu H; Yu Q
Exp Dermatol; 2022 Apr; 31(4):582-585. PubMed ID: 35020224
[TBL] [Abstract][Full Text] [Related]
59. Expanding mutational spectrum of HRAS by a patient with Schimmelpenning-Feuerstein-Mims syndrome.
Luo Q; Zhang Q; Shen J; Guan W; Li M; Zhang J; Tan Z
J Dermatol; 2021 Aug; 48(8):1273-1276. PubMed ID: 34109654
[TBL] [Abstract][Full Text] [Related]
60. Epidermal nevus syndromes.
Sugarman JL
Semin Cutan Med Surg; 2007 Dec; 26(4):221-30. PubMed ID: 18395670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
